Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000817240 | SCV000957790 | uncertain significance | Familial acute necrotizing encephalopathy | 2022-02-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 660110). This variant has not been reported in the literature in individuals affected with RANBP2-related conditions. This variant is present in population databases (rs773526624, gnomAD 0.03%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1505 of the RANBP2 protein (p.Pro1505Leu). |
Ambry Genetics | RCV004669139 | SCV005156725 | uncertain significance | not specified | 2024-04-17 | criteria provided, single submitter | clinical testing | The c.4514C>T (p.P1505L) alteration is located in exon 20 (coding exon 20) of the RANBP2 gene. This alteration results from a C to T substitution at nucleotide position 4514, causing the proline (P) at amino acid position 1505 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |